The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis
作者： Xiao-Dong Jing , Xiao-Ming Wei , Song-Bai Deng , Jian-Lin Du , Ya-Jie Liu
DOI: 10.1016/J.CCA.2015.04.038
关键词: Cardiology 、 High-density lipoprotein 、 Beneficial effects 、 Restenosis 、 Internal medicine 、 Sphingosine-1-phosphate 、 In stent restenosis 、 Inflammation 、 Normal control 、 Lipoprotein 、 Medicine
摘要: Abstract Background High-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) contributed to several beneficial effects in the cardiovascular system. We explored relationship between HDL-S1P concentrations and coronary in-stent restenosis (ISR). Methods Fifty consecutive patients with ISR 50 normal control subjects were included. The serum S1P, clinical data collected explore relationships these parameters ISR. Results had significantly lower of S1P (96.10 ± 26.33 vs. 113.40 ± 32.72; P = 0.004) (32.81 ± 10.02 42.72 ± 11.75; P Conclusions is an independent predictor ISR, higher have a low risk
elsevier.com
sci-hub.se 参考文章(20)
Jeffrey W. Moses, Gregg W. Stone, Eugenia Nikolsky, Gary S. Mintz, George Dangas, Eberhard Grube, Stephen G. Ellis, Alexandra J. Lansky, Giora Weisz, Martin Fahy, Yingbo Na, Mary E. Russell, Dennis Donohoe, Martin B. Leon, Roxana Mehran, Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. Journal of the American College of Cardiology. ,vol. 47, pp. 2164- 2171 ,(2006) , 10.1016/J.JACC.2006.01.068
Xuan Gj, Chun Zf, Paudel B, Analysis of clinical factors affecting the restenosis following percutaneous coronary intervention. Nepal Medical College journal. ,vol. 7, pp. 101- ,(2005)
Kyle J. Smith, Gregory J. Dehmer, Drug-eluting coronary artery stents. American Family Physician. ,vol. 80, pp. 1245- 1251 ,(2009)
Maria L. Allende, Tadashi Yamashita, Richard L. Proia, G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation Blood. ,vol. 102, pp. 3665- 3667 ,(2003) , 10.1182/BLOOD-2003-02-0460
Naoya MURATA, Koichi SATO, Junko KON, Hideaki TOMURA, Masayo YANAGITA, Atsushi KUWABARA, Michio UI, Fumikazu OKAJIMA, Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochemical Journal. ,vol. 352, pp. 809- 815 ,(2000) , 10.1042/BJ3520809
Pu Xia, Mathew A. Vadas, Kerry-Anne Rye, Philip J. Barter, Jennifer R. Gamble, High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL. Journal of Biological Chemistry. ,vol. 274, pp. 33143- 33147 ,(1999) , 10.1074/JBC.274.46.33143
Anna L. Guildford, Helen J. S. Stewart, Christopher Morris, Matteo Santin, Substrate-induced phenotypic switches of human smooth muscle cells: an in vitro study of in-stent restenosis activation pathways Journal of the Royal Society Interface. ,vol. 8, pp. 641- 649 ,(2011) , 10.1098/RSIF.2010.0532
Tian Lan, Huichang Bi, Weihua Liu, Xi Xie, Suowen Xu, Heqing Huang, Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography–tandem mass spectrometry Journal of Chromatography B. ,vol. 879, pp. 520- 526 ,(2011) , 10.1016/J.JCHROMB.2011.01.015
Francesco Versaci, Achille Gaspardone, Prevention of restenosis after stenting: the emerging role of inflammation. Coronary Artery Disease. ,vol. 15, pp. 307- 311 ,(2004) , 10.1097/00019501-200409000-00002
Kelley M. Argraves, Patrick J. Gazzolo, Eric M. Groh, Brent A. Wilkerson, Bryan S. Matsuura, Waleed O. Twal, Samar M. Hammad, W. Scott Argraves, High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. Journal of Biological Chemistry. ,vol. 283, pp. 25074- 25081 ,(2008) , 10.1074/JBC.M801214200